Solventum: The Identity Of 3M’s Health Care Spin-Off

3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum. 

Spin off

3M’s $8.4bn health care division will be spun out from the company in the first half of 2024 under plans announced this week. The new entity will be known as Solventum, a portmanteau of “solving” and “momentum.”

The company originally expected to complete the tax-free transaction by year-end 2023. (Also see "3M Plans To Spin Off Health Care Business By The End Of 2023" - Medtech...

More from Business

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By 

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.